Centor
Centor is a US subsidiary of Gerresheimer AG that manufactures child-resistant prescription vials, bottles, closures, liquid ovals, ointment jars, droppers, and the Gx Cap smart adherence closure, sold directly to retail, mail-order, and veterinary pharmacies.
- Company typePrivate
- Founded1987
- HeadquartersPerrysburg, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Centor does
Centor, Inc. is a Perrysburg, Ohio-based manufacturer of plastic and glass prescription packaging, operating as a wholly-owned US subsidiary of German MDAX-listed Gerresheimer AG. The company produces child-resistant vials and closures (1-Clic®, Screw-Loc®), non-child-resistant snap-cap vials (Plastainer®), round PP and PET bottles and closures (Ultra-Loc®), liquid ovals, ointment jars, droppers, and applicators for retail, mail-order/central-fill, and veterinary pharmacy customers. Its product portfolio is engineered to meet CPSC child-resistance standards, USP 671 light and moisture transmission requirements, and ISO 9001 / 15378 / 45001 certifications, and is designed for compatibility with robotic pharmacy automation systems used in high-volume mail-order operations.
The business operates a B2B sales-led go-to-market, selling direct to pharmacies through a national team of regional account managers covering defined US territories and supporting customer acquisition through major pharmacy industry trade shows (RBC, Thoughtspot, NACDS, NCPA). Revenue is generated through hardware sales of consumable packaging products with recurring reorder patterns from pharmacy customers. Centor claims market-share leadership in regulatory-compliant prescription containers in the US and reports a 2:1 consumer preference ratio for its 1-Clic® closure versus alternatives. More recently, the company has expanded its product surface into connected health through the Gx Cap, an LTE-powered smart closure that monitors vial openings, dispatches medication adherence reminders, and enables pharmacist-led remote monitoring programs.
The company is currently the subject of a strategic restructuring at the parent level: Gerresheimer AG engaged Morgan Stanley to divest Centor (book value €292 million) with a target closing before end of fiscal year 2026, alongside the announced closure of the Chicago Heights, Illinois glass factory (172 layoffs) and a broader parent-level debt refinancing effort. These moves are occurring against the backdrop of a BaFin investigation into Gerresheimer's accounting practices, a CEO change at the parent, and an ongoing KPMG audit review.
Centor firmographics
Firmographics- Name
- Centor
- Legal name
- Centor, Inc.
- Website
- http://www.centorrx.com/
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Centor is a US subsidiary of Gerresheimer AG that manufactures child-resistant prescription vials, bottles, closures, liquid ovals, ointment jars, droppers, and the Gx Cap smart adherence closure, sold directly to retail, mail-order, and veterinary pharmacies.
- Ownership category
- akta.pro rank
Centor industry classification
Industry- Product category
- Pharmaceutical Packaging
- NAICS
- Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA)
- akta.pro secondary industries
- Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features) (IMALAIAJ), Medication Adherence, Packaging & Fulfillment Services (Blister/Unit-Dose) (HLAFALAJ)
Keywords
Where Centor is headquartered
LocationHeadquarters
- HQ city
- Perrysburg
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Centor business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Packaging Products: Manufactures and sells prescription packaging containers including vials, bottles, closures, liquid ovals, ointment jars, and droppers to pharmacies and healthcare providers. Revenue is generated through product sales with recurring reorder patterns from pharmacy customers.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels3 records
Centor product offering
Product offeringCore offering
Centor manufactures plastic vials, closures, bottles, liquid ovals, ointment jars, droppers, and applicators for retail, mail-order, and veterinary pharmacies to dispense prescription medications. Its flagship offerings include child-resistant Screw-Loc® and 1-Clic® packaging systems compliant with CPSC and USP standards, plus the Gx Cap LTE-enabled smart closure for medication adherence monitoring.
Product overview
Centor is a prescription packaging company offering a comprehensive portfolio of regulatory-compliant medication containers and smart monitoring solutions. The core product line centers on child-resistant vials and closures (1-Clic®, Screw-Loc®, Plastainer®), complemented by bottles, liquid ovals, ointment jars, and droppers/applicators. The product portfolio includes plastic options made from recycled PET resin and glass alternatives. The Gx Cap smart closure represents a connected add-on module that adds LTE-enabled adherence monitoring to the core 1-Clic vial packaging system. Centor positions itself as serving retail, mail, veterinary, and other pharmacy dispensing segments.
Differentiator
Problem solved
Functional benefit
Brands
- 1-Clic®: Child-resistant vial and closure packaging system, popular and preferred by consumers for dispensed medications
- Screw-Loc®
- Plastainer®
- Ultra-Loc®
- Gx Cap
Products and services
- 1-Clic® Vial & Closure
Quantifiable outcome
- 40% moisture barrier improvement with LeneX™ UltraGuard® technology
- +2 more outcomes
Companies that use Centor
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Centor technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
Centor partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- KPMGcoreKPMG has been investigating accounting irregularities at Gerresheimer, including potential revenue misstatements and leasing liability issues. The investigation has expanded to include examination of development costs.
Scale indicators5 records
Recent moves2 records
Expansion highlights5 records
Centor competitors and assessment
Company assessmentDirect peers
- Stevanato Group: Specialty pharmaceutical containment provider offering vials, closures, and integrated drug delivery solutions. Directly comparable to Centor in regulated primary packaging for pharmacy and biopharma customers.
- DWK Life Sciences: Manufacturer of glass and plastic containers for pharmaceutical, diagnostic, and laboratory applications, including amber bottles and closures similar to Centor's liquid oval and bottle ranges.
- AptarGroup: Aptar is a global supplier of dispensing closures, child-resistant packaging, and drug delivery components to pharmaceutical and consumer-health customers. It directly competes with Centor in pharmacy-grade child-resistant vial/closure systems.
- SGD Pharma: Specialty pharmaceutical glass packaging supplier producing glass vials, bottles, and closures. Overlaps with Centor's glass primary packaging lines serving pharmacy customers.
- Comar: US-based specialty plastic packaging manufacturer serving pharmaceutical, healthcare, and consumer markets, including closures, bottles, and prescription containers that directly overlap with Centor's vial and closure portfolio.
Broad incumbents
- TricorBraun: Large rigid packaging distributor and manufacturer offering bottles, closures, and containers to pharma, personal care, and food markets. Adjacent competitor to Centor in pharmacy packaging with broader end-market reach.
- Amcor: Global packaging conglomerate with healthcare and rigid-plastic packaging divisions offering prescription bottles, closures, and pharmacy packaging comparable to Centor's product range, including recyclable PET options.
- Gerresheimer AG: Centor's parent and the largest dedicated pharmaceutical packaging company globally. Gerresheimer's Primary Packaging Plastics business includes Centor and offers overlapping prescription vial/bottle and rigid plastic packaging solutions to the same pharmacy customer set.
- Schott AG: Specialty glass manufacturer with a strong pharmaceutical packaging business (vials, ampoules, syringes) serving many of the same pharmacies and pharmaceutical customers as Centor, including glass liquid ovals that compete with Centor's glass oval line.
- West Pharmaceutical Services: A leading provider of primary packaging and delivery components for injectable and oral pharmaceuticals. Overlaps with Centor in regulated primary packaging for dispensed medications and offers a broader pharma containment portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Centor social profiles
Digital presenceCentor compliance and trust
Trust signalCompliance8 records
Centor financial estimates
Financial estimateRevenue estimate
Valuation estimate
Centor leadership team
Management profileNumber of profiles
Profiles15 records
Centor funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Centor M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Centor
What does Centor do?
Centor manufactures plastic vials, closures, bottles, liquid ovals, ointment jars, droppers, and applicators for retail, mail-order, and veterinary pharmacies to dispense prescription medications. Its flagship offerings include child-resistant Screw-Loc® and 1-Clic® packaging systems compliant with CPSC and USP standards, plus the Gx Cap LTE-enabled smart closure for medication adherence monitoring.
Is Centor a public or private company?
Centor is a private company. It is classified as corporate owned and is currently operating.
When was Centor founded?
Centor was founded in 1987. It employs 51 to 100 people.
Where is Centor based?
Centor is headquartered in Perrysburg, United States, in the North America region.
How does Centor make money?
One revenue line is on record: pharmaceutical Packaging Products.
Who are Centor's main competitors?
Direct peers on record are Stevanato Group, DWK Life Sciences, AptarGroup, SGD Pharma and Comar. Broad incumbents are TricorBraun, Amcor, Gerresheimer AG, Schott AG and West Pharmaceutical Services.
Does Centor have an API?
No public API is recorded for Centor.
What industry is Centor in?
Centor's product category is Pharmaceutical Packaging. Its primary akta.pro industry code is IMALAIAA, Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules), with a secondary code of IMALAIAJ, Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features). Its NAICS code is 3391 and its SIC code is 3841.